David N. Rose

1.6k total citations
36 papers, 1.2k citations indexed

About

David N. Rose is a scholar working on Epidemiology, Infectious Diseases and General Health Professions. According to data from OpenAlex, David N. Rose has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 16 papers in Infectious Diseases and 5 papers in General Health Professions. Recurrent topics in David N. Rose's work include Tuberculosis Research and Epidemiology (9 papers), Influenza Virus Research Studies (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). David N. Rose is often cited by papers focused on Tuberculosis Research and Epidemiology (9 papers), Influenza Virus Research Studies (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). David N. Rose collaborates with scholars based in United States. David N. Rose's co-authors include Michael B. Rothberg, Henry S. Sacks, Clyde B. Schechter, Peter K. Lindenauer, Ivo Abraham, Alan Silver, Sandra Bellantonio, Marianne C. Fahs, Brendan P. Kelly and Joseph Wiesel and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

David N. Rose

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David N. Rose United States 21 577 439 234 184 139 36 1.2k
Stephen D. Nightingale United States 19 951 1.6× 762 1.7× 170 0.7× 165 0.9× 73 0.5× 38 1.6k
Frederic E. Shaw United States 17 509 0.9× 219 0.5× 192 0.8× 72 0.4× 95 0.7× 29 1.0k
Mehran S. Massoudi United States 21 670 1.2× 928 2.1× 248 1.1× 228 1.2× 132 0.9× 36 2.0k
David Stanton United States 13 436 0.8× 592 1.3× 268 1.1× 194 1.1× 62 0.4× 22 1.0k
C Sox United States 19 388 0.7× 205 0.5× 386 1.6× 71 0.4× 202 1.5× 32 1.3k
Lisa Nelson United States 19 749 1.3× 995 2.3× 130 0.6× 430 2.3× 56 0.4× 48 1.6k
Felicity Fitzgerald United Kingdom 21 295 0.5× 221 0.5× 307 1.3× 82 0.4× 99 0.7× 104 1.4k
Bich N. Dang United States 13 250 0.4× 368 0.8× 372 1.6× 126 0.7× 68 0.5× 30 944
Beth F. Hibbs United States 15 580 1.0× 375 0.9× 167 0.7× 105 0.6× 37 0.3× 32 1.4k
Ezekiel Mupere Uganda 25 556 1.0× 816 1.9× 170 0.7× 239 1.3× 36 0.3× 114 1.7k

Countries citing papers authored by David N. Rose

Since Specialization
Citations

This map shows the geographic impact of David N. Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David N. Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David N. Rose more than expected).

Fields of papers citing papers by David N. Rose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David N. Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David N. Rose. The network helps show where David N. Rose may publish in the future.

Co-authorship network of co-authors of David N. Rose

This figure shows the co-authorship network connecting the top 25 collaborators of David N. Rose. A scholar is included among the top collaborators of David N. Rose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David N. Rose. David N. Rose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Silva, Tracy‐Anne De & David N. Rose. (2023). Manaaki Tauira Course Enhancements Program. ASCILITE Publications. 388–392. 1 indexed citations
2.
McComb, Sara, et al.. (2012). Improving Teamwork on General Medical Units: When Teams Do Not Work Face-to-Face. The Joint Commission Journal on Quality and Patient Safety. 38(10). 471–478. 11 indexed citations
3.
Rothberg, Michael B., Aleta B. Bonner, M. Hasan Rajab, Barbara W. Stechenberg, & David N. Rose. (2008). Do pediatricians manage influenza differently than internists?. BMC Pediatrics. 8(1). 15–15. 2 indexed citations
4.
Rothberg, Michael B. & David N. Rose. (2005). Vaccination versus treatment of influenza in working adults: A cost-effectiveness analysis. The American Journal of Medicine. 118(1). 68–77. 86 indexed citations
5.
Rothberg, Michael B., et al.. (2005). Effects of Local Variation, Specialty, and Beliefs on Antiviral Prescribing for Influenza. Clinical Infectious Diseases. 42(1). 95–99. 39 indexed citations
6.
Rothberg, Michael B., Donna Fisher, Brendan P. Kelly, & David N. Rose. (2005). Management of Influenza Symptoms in Healthy Children. Archives of Pediatrics and Adolescent Medicine. 159(11). 1055–1055. 33 indexed citations
7.
Rothberg, Michael B., Ivo Abraham, Peter K. Lindenauer, & David N. Rose. (2005). Improving Nurse-to-Patient Staffing Ratios as a Cost-Effective Safety Intervention. Medical Care. 43(8). 785–791. 126 indexed citations
8.
Rothberg, Michael B., et al.. (2003). Management of influenza symptoms in healthy adults. Journal of General Internal Medicine. 18(10). 808–815. 40 indexed citations
9.
Rose, David N.. (2000). Benefits of Screening for Latent Mycobacterium tuberculosis Infection. Archives of Internal Medicine. 160(10). 1513–1513. 58 indexed citations
10.
Rose, David N., et al.. (1999). Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective. AIDS. 13(12). 1549–1556. 58 indexed citations
11.
Rose, David N., et al.. (1997). BCG Vaccination to Prevent Tuberculosis in Health Care Workers: A Decision Analysis. Preventive Medicine. 26(2). 201–207. 12 indexed citations
12.
Rose, David N. & Henry S. Sacks. (1997). Cost-effectiveness of cytomegalovirus (CMV) disease prevention in patients with AIDS. AIDS. 11(7). 883–887. 24 indexed citations
13.
Rose, David N., et al.. (1995). Interpretation of the tuberculin skin test. Journal of General Internal Medicine. 10(11). 635–642. 65 indexed citations
14.
Rose, David N., et al.. (1993). Survival of Elderly Patients with Transfusion‐Related Acquired Immunodeficiency Syndrome. Journal of the American Geriatrics Society. 41(3). 214–216. 25 indexed citations
15.
Rose, David N., Clyde B. Schechter, & Henry S. Sacks. (1993). Influenza and pneumococcal vaccination of HIV-infected patients: A policy analysis. The American Journal of Medicine. 94(2). 160–168. 58 indexed citations
16.
Rose, David N., Clyde B. Schechter, & Henry S. Sacks. (1992). Preventive medicine for HIV-infected patients. Journal of General Internal Medicine. 7(6). 589–594. 9 indexed citations
17.
Sacks, Henry S. & David N. Rose. (1990). Zidovudine prophylaxis for needlestick exposure to human immunodeficiency virus. Journal of General Internal Medicine. 5(2). 132–137. 26 indexed citations
18.
Rose, David N., Alan Silver, & Clyde B. Schechter. (1988). Isoniazid for the Tuberculin Reactor: Take it or Leave it. American Review of Respiratory Disease. 138(2). 489–490. 2 indexed citations
19.
Rose, David N., et al.. (1987). Hearing Loss Screening in the Neonatal Intensive Care Unit. Ear and Hearing. 8(4). 213–216. 23 indexed citations
20.
Bosch, Samuel, et al.. (1986). Community Participation in New York City: Success or Failure?. American Journal of Preventive Medicine. 2(4). 198–204. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026